Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
LSDIF
Upturn stock ratingUpturn stock rating

Lucy Scientific Discovery Inc. (LSDIF)

Upturn stock ratingUpturn stock rating
$0.01
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/25/2025: LSDIF (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.01
high$

Analysis of Past Performance

Type Stock
Historic Profit -11.29%
Avg. Invested days 6
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/25/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 0.00M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -37.69
52 Weeks Range 0.00 - 0.50
Updated Date 05/10/2025
52 Weeks Range 0.00 - 0.50
Updated Date 05/10/2025
Dividends yield (FY) -
Basic EPS (TTM) -7.64

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -8906.54%

Management Effectiveness

Return on Assets (TTM) -99.35%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2002470
Price to Sales(TTM) 0.02
Enterprise Value 2002470
Price to Sales(TTM) 0.02
Enterprise Value to Revenue 119.68
Enterprise Value to EBITDA -9.52
Shares Outstanding 1764760
Shares Floating 1460178
Shares Outstanding 1764760
Shares Floating 1460178
Percent Insiders 18.03
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Lucy Scientific Discovery Inc.

stock logo

Company Overview

overview logo History and Background

Lucy Scientific Discovery Inc. (LSDI) was incorporated in 2021. It focuses on the manufacturing of pharmaceutical-grade cannabinoid APIs and psychedelics. The company operates within the evolving landscape of pharmaceutical cannabinoid and psychedelic compounds.

business area logo Core Business Areas

  • Pharmaceutical-Grade Cannabinoid APIs Manufacturing: Focuses on the production of cannabinoid Active Pharmaceutical Ingredients (APIs) that meet pharmaceutical standards.
  • Psychedelics: Manufacturing of pharmaceutical-grade psychedelics.

leadership logo Leadership and Structure

The leadership structure includes a CEO and a board of directors. Specific details about the team composition are best obtained directly from the company's website or regulatory filings.

Top Products and Market Share

overview logo Key Offerings

  • Pharmaceutical-Grade Cannabinoid APIs: Active pharmaceutical ingredients derived from cannabinoids, targeting pharmaceutical companies for research and drug development. Market share data is currently unavailable. Competitors include companies specializing in cannabinoid API manufacturing.
  • Psychedelics: Active pharmaceutical ingredients derived from psychedelic drugs, targeting pharmaceutical companies for research and drug development. Market share data is currently unavailable. Competitors include companies specializing in psychedelic API manufacturing.

Market Dynamics

industry overview logo Industry Overview

The cannabinoid and psychedelic API market is growing, driven by increasing research into therapeutic applications and evolving regulatory frameworks.

Positioning

Lucy Scientific Discovery Inc. aims to be a key player in the manufacturing and supply of pharmaceutical-grade cannabinoid and psychedelic APIs. Its competitive advantage lies in its manufacturing capabilities, quality standards and regulatory compliance. However the industry is fragmented and still developing.

Total Addressable Market (TAM)

The TAM for pharmaceutical-grade cannabinoid and psychedelic APIs is projected to grow significantly in the coming years, however specific numbers are difficult to verify. Lucy Scientific Discovery Inc. is positioned to capture a share of this growing market through its focus on quality and compliance. No official guidance given.

Upturn SWOT Analysis

Strengths

  • Specialized manufacturing capabilities
  • Focus on pharmaceutical-grade quality
  • Early mover advantage in a nascent market

Weaknesses

  • Limited operating history
  • Small Market Cap
  • High dependence on regulatory approvals
  • Financial instability

Opportunities

  • Expanding research into cannabinoid and psychedelic therapies
  • Evolving regulatory landscape favoring licensed manufacturers
  • Strategic partnerships with pharmaceutical companies

Threats

  • Competition from larger pharmaceutical companies
  • Changes in regulations impacting cannabinoid and psychedelic products
  • Market acceptance of cannabinoid and psychedelic therapies
  • Financing risks.

Competitors and Market Share

competitor logo Key Competitors

  • Cronos Group (CRON)
  • Canopy Growth Corporation (CGC)
  • Aurora Cannabis (ACB)

Competitive Landscape

Lucy Scientific Discovery Inc. faces competition from established players in the cannabis industry. Its advantages include focus on pharmaceutical-grade APIs. Its disadvantages include a smaller market share and financial constraints compared to competitors.

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends are not available due to the company's limited operating history.

Future Projections: Future growth projections require access to analyst estimates and company guidance. These are not available for the current date.

Recent Initiatives: Recent initiatives include manufacturing agreements and strategic partnerships aimed at expanding its market presence. Details are best found in company press releases.

Summary

Lucy Scientific Discovery Inc. is a relatively new company focused on the growing market of pharmaceutical-grade cannabinoid and psychedelic APIs. It has potential due to its specialized manufacturing capabilities and focus on quality. However, its limited operating history, reliance on regulatory approvals, and competition from established players present significant challenges. The company's long-term success will depend on its ability to secure partnerships, navigate the evolving regulatory landscape, and effectively market its products.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Lucy Scientific Discovery Inc.

Exchange NASDAQ
Headquaters Victoria, BC, Canada
IPO Launch date 2023-02-09
CEO & Executive Chair Mr. Richard D. Nanula
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 2
Full time employees 2

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.